Notice of Clarification for PAR-23-269, PAR-23-125, "NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) and Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)"
National Institutes of Health
Typ
Research/project funding
Posted on:
Notice NOT-DA-24-034 from the NIH Guide for Grants and Contracts